The bystander result also points out, partially, why Enhertu is effective from tumors that have hardly any HER2: as soon as the ADC enters a tumor as well as the drug molecules detach, they will destroy neighboring tumor cells even if those bystanders don’t carry much HER2 on their own surface area. This motion, along with the utilization of a di